ACHIEVE LIFE SCIENCES INC (ACHV)       5.2  +0.21 (+4.21%)

5.2  +0.21 (+4.21%)

US0044685008 - Common Stock

ACHIEVE LIFE SCIENCES INC5.2

NASDAQ:ACHV (2/3/2023, 7:23:14 PM)+0.21 (+4.21%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Biotechnology

Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend

Overview
Earnings (Last) 11-14 2022-11-14/amc Earnings (Next) 03-08 2023-03-08/amc
Ins Owners 0.63% Inst Owners 21.85%
Market Cap 50.50M Shares 9.71M
PE N/A Fwd PE N/A
Dividend Yield N/A Analysts 84.62
IPO 10-12 1995-10-12

Stock Screener Links

Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

ACHV Daily chart

Company Profile

Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. The company is headquartered in Seattle, Washington and currently employs 16 full-time employees. The firm is engaged in development and commercialization of cytisinicline for smoking cessation and nicotine addiction. The Company’s product candidate, cytisinicline, is a naturally occurring plant-based alkaloid from the seeds of the Laburnum anagyroides plant. Cytisinicline is structurally similar to nicotine and a mechanism of action that is both agonistic and antagonistic. The firm is aid in smoking cessation, or nicotine addiction, by interacting with nicotine receptors in the brain by reducing the severity of nicotine withdrawal symptoms through agonistic effects on nicotine receptors and by reducing the reward and satisfaction associated with nicotine through antagonistic properties. The Company’s has two prescription oral treatments for smoking cessation are available in the United States: Chantix (varenicline) and Zyban (bupropion).

Company Info

ACHIEVE LIFE SCIENCES INC

22722 29Th Dr. Se, Suite 100

Seattle WASHINGTON V6E 4H1

P: 14256861500.0

CEO: John Bencich

Employees: 16

Website: http://achievelifesciences.com/

ACHV News

News Image3 days ago - Achieve Life SciencesAchieve Life Sciences to Participate at the 2023 SVB Securities Global Biopharma ConferenceNews Image9 days ago - Achieve Life SciencesAchieve Life Sciences Announces Granting of New Hire Inducement AwardNews Image9 days ago - Achieve Life SciencesAchieve Life Sciences Announces Granting of New Hire Inducement Award

SEATTLE, Wash and VANCOUVER, British Columbia, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical...

News Imagea month ago - Achieve Life SciencesAchieve Life Sciences Announces Last Subject Dosed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking CessationNews Image2 months ago - Achieve Life SciencesAchieve Life Sciences Announces Patent Granted by USPTO for New Cytisinicline Formulation

SEATTLE, Wash and VANCOUVER, British Columbia, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage...

News Image2 months ago - Achieve Life SciencesAchieve Life Sciences Announces Patent Granted by USPTO for New Cytisinicline Formulation

ACHV Twits

Here you can normally see the latest stock twits on ACHV, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example